According to a new market report by Lucintel, the future of the needle free drug delivery device market looks promising with opportunities in the vaccine delivery, pain management, insulin delivery for diabetes, and pediatric injection applications. The needle free drug delivery device market is expected to grow with a CAGR of 10% from 2019 to 2024. The major drivers for this market are rising usage of injections in healthcare sector, increase in incidence of needle born disease, and surging demand and technological advancements in the field of pain-free drug transportation and self-administration.

In this market, various technologies are used for needle free drug delivery, such as jet injectors, inhaler technology, transdermal patch, and novel needle free technology. Jet injectors is the largest technology segment of the needle free drug delivery device market.

Within this market, vaccine delivery, pain management, insulin delivery for diabetes, and pediatric injections are the major application segment. Insulin delivery is the largest application segment of the needle free drug delivery device market

North America will remain the largest region over the forecast period due to high awareness regarding potential benefits of needle-free drug delivery devices, presence of well-developed healthcare facilities, and extensive R&D expenditure by government organizations.

Antares Pharma, Injex Pharma AG, 3M, PharmaJet, Zogenix, Bioject Medical Technologies, Glide Pharmaceutical Technologies, Penjet Corporation, Valeritas, and D'Antonio Consultants International are among the major manufacturers of needle free drug delivery device market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the needle free drug delivery device market by technology, application, and region. Lucintel has prepared a comprehensive research report titled " Needle Free Drug Delivery Device market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the needle free drug delivery device market by technology, application, and region as follows:

By Technology [$M shipment analysis for 2013 – 2024]:
• Jet Injectors
• Inhaler Technology
• Transdermal Patch Technology
• Novel Needle Free Technologies
By Application [$M shipment analysis for 2013 – 2024]:
• Vaccine Delivery
• Pain Management
• Insulin Delivery For Diabetes
• Pediatric Injections
• Others
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
• Asia-Pacific
o China
o Japan
o India
• Rest of the World
o Brazil

This report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report answers following 11 key questions:

Q.1 What are some of the most promising potential, high-growth opportunities for the needle free drug delivery device market by technology (jet injectors, inhaler technology, transdermal patch technology, and novel needle free technologies), application (vaccine delivery, pain management, insulin delivery for diabetes, pediatric injections, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which regions will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the needle free drug delivery device market?
Q.5 What are the business risks and threats to the needle free drug delivery device market?
Q.6 What are emerging trends in this needle free drug delivery device market and the reasons behind them?
Q.7 What are some changing demands of customers in the needle free drug delivery device market?
Q.8 What are the new developments in the needle free drug delivery device market? Which companies are leading these developments?
Q.9 Who are the major players in this needle free drug delivery device market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this needle free drug delivery devices area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M & A activities have taken place in the last 5 years in this needle free drug delivery device market?